Next Article in Journal
The Effect of Omalizumab on Eosinophilic Inflammation of the Respiratory Tract in Patients with Allergic Asthma
Previous Article in Journal
Can Pancreatic Tissue Cause Haemoptysis?
 
 
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Pharmaceutical Care in Asthma—Polish and Global Perspective

by
Damian Swieczkowski
1,*,
Patryk Poniatowski
2,
Piotr Merks
3 and
Milosz Jaguszewski
1
1
First Department of Cardiology, Medical University of Gdansk, Poland, Debinki 7, 80-952 Gdansk, Poland
2
Community Pharmacist, Lancaster, UK
3
Department of Pharmaceutical Technology, Faculty of Pharmacy Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Toruń, Poland
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2016, 84(4), 225-231; https://doi.org/10.5603/PiAP.2016.0028
Submission received: 13 March 2016 / Revised: 14 July 2016 / Accepted: 14 July 2016 / Published: 14 July 2016

Abstract

The pharmaceutical care is a pharmacist’s contribution to the care of individual patients and leads to optimize the use of drugs. The pharmaceutical care may improve adherence, clinical effectiveness of providing therapy and improve the health-related quality of life. The conducted literature review confirmed that pharmaceutical care and advanced pharmaceutical services are clinical effective in asthma. The implementation of pharmaceutical care under Polish conditions is currently insufficient and remains challenging for the future. Herein we should admit, that the polish government has recently put an effort to appoint specially dedicated team establishing a program of reimbursed pharmaceutical care. This move should be considered as a new phase for amendments community pharmacy in Poland. The experience of different health care systems, including for instance United Kingdom, Australia or Canada, might be used in the process of changing Polish perspective. Herein, we have reviewed the literature and highlighted the services creating the program of pharmaceutical care in asthma. This unique work describes the complex nature of optimal pharmaceutical services emphasizing the strong necessity of multidimensional approach in this field.
Keywords: pharmaceutical care; asthma; community pharmacy pharmaceutical care; asthma; community pharmacy

Share and Cite

MDPI and ACS Style

Swieczkowski, D.; Poniatowski, P.; Merks, P.; Jaguszewski, M. The Pharmaceutical Care in Asthma—Polish and Global Perspective. Adv. Respir. Med. 2016, 84, 225-231. https://doi.org/10.5603/PiAP.2016.0028

AMA Style

Swieczkowski D, Poniatowski P, Merks P, Jaguszewski M. The Pharmaceutical Care in Asthma—Polish and Global Perspective. Advances in Respiratory Medicine. 2016; 84(4):225-231. https://doi.org/10.5603/PiAP.2016.0028

Chicago/Turabian Style

Swieczkowski, Damian, Patryk Poniatowski, Piotr Merks, and Milosz Jaguszewski. 2016. "The Pharmaceutical Care in Asthma—Polish and Global Perspective" Advances in Respiratory Medicine 84, no. 4: 225-231. https://doi.org/10.5603/PiAP.2016.0028

APA Style

Swieczkowski, D., Poniatowski, P., Merks, P., & Jaguszewski, M. (2016). The Pharmaceutical Care in Asthma—Polish and Global Perspective. Advances in Respiratory Medicine, 84(4), 225-231. https://doi.org/10.5603/PiAP.2016.0028

Article Metrics

Back to TopTop